31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Construction workers are permitted to continue working in New Jersey, but projects must reduce onsit...
Read More >
In this episode, Akin Gump international competition and trade partner Davina Garrod and corporate p...
Read More >
Saudi Aramco’s mega IPO plans are back on, and while valuation and other stumbling blocks remain, t...
Read More >
On July 3, 2019, the National Labor Relations Board (NLRB) modified the legal framework in which an ...
Read More >
Any illusions that OFCCP would disappear during the Trump Administration should have already been pu...
Read More >
Anyone who hires someone to do construction should ask the contractor to name them as an additional ...
Read More >